Media
1096 Articles
Reuters:  Toyota (NYSE:TM) returned to a profit. Reuters:  The Fed will keep rates near zero for an extended period. Reuters:  …
We have seen earnings from five of the thirty DJIA components this morning alone. All were above expectations, even if…
We have already run the 5 of the 30 DJIA components that reported earnings this morning. But we still have…
The short interest in Apple (NASDAQ:AAPL) was steady in the period that ended on September 30 at 16 million shares.The…
Wasn’t it just last week that we were up eight days in a row on the DJIA? And now we…
Reuters:  UBS (UBS) shares may fall when the Swiss government sells out. Reuters:  The US deficit estimate was trimmed to…
Reuters:  Banks paid out billions of dollars in bonuses last year while losing money. Reuters:  The US closed its car…
Short sellers are will to bet, at least for now, that the worst of the banking earning crisis is over.…
Reuters: Microsoft’s (MSFT) results and forecast were weak. Reuters:  CIT (CIT) may sell its aviation finance business. Reuters:  Fatigue at…
Safety and efficacy data are critical to drug candidates. But what really makes a potential drug attractive is strong top-line…
Apple’s beat Wall St. consensus figures by posting earnings per share of $1.35 compared to Wall St. expectations of $1.17.…
These are some of this morning’s top stocks to watch for active trading today based on pre-market and after-hours volume…
So far we have three DJIA components with earnings out. DuPont (NYSE: DD), Merck & Co. (NYSE: MRK), United Technologies…
This week will mark the first crest of earnings season as we have 11 of the 30 DJIA components reporting…
Here are some of today’s top stories affecting key drug and biotech stocks, accompanied with links through to more detailed…
Our top personal finance-related articles today. Your wallet will thank you later.